NUVL Nuvalent, Inc.
Healthcare$104.95+2.77%ClosedMarket Cap: $7.72B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$189.00
Target (Median)
$189.00
Target Range
$189.00 - $189.00
Upside from current price: 80.1%
Rating Distribution
4 Strong Buy16 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-08 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-27 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-12-19 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-18 | Goldman Sachs | maintain | Buy | Buy |
| 2025-11-18 | Guggenheim | maintain | Buy | Buy |
| 2025-11-18 | Baird | maintain | Outperform | Outperform |
| 2025-11-17 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-11-17 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-17 | Stifel | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.38 | $182.7M | 14 |
| Sun Dec 31 | $-1.53 | $498.6M | 14 |
| Mon Dec 31 | $2.77 | $916.6M | 8 |
| Tue Dec 31 | $5.38 | $1.26B | 12 |